The trademark application was filed by Wifussion Medtech Co., Ltd. Chongqing Pharmaceutical Group, a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on November 22, 2023, and it was registered by office on February 29, 2024 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on November 27, 2023.